Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso, a combination ...
FDA approves 1st 2-drug HIV treatment combining doravirine and islatravir for adults with suppressed HIV-1, offering a ...
Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable ...
The FDA has approved Idvynso (doravirine/islatravir) for virologically suppressed adults with HIV-1 as a replacement for current treatment regimens.
Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...
A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...
The newly approved HIV drug Idvynso will also help Merck diversify as loss of exclusivity looms over its top-selling product, ...
FDA approves doravirine/islatravir, a once-daily, 2-drug, single-tablet HIV regimen showing noninferior efficacy to standard ...
After a year without data, the State Department released figures on PEPFAR, the program launched by George W. Bush and ...
Every year, National Native HIV/AIDS Awareness Day (NNHAAD) provides an opportunity to highlight the impact of HIV/AIDS on Indigenous communities across the United States. This day focuses on ...
In theory, it has become miraculously easy to avoid getting HIV in the United States today. | Xinmei Liu for Vox Brenton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results